[esi adrotate group="1" cache="private" ttl="0"]

Young women with breast cancer lecture

Young women with breast cancer and Leah Lederman Lecture: This webinar aims to teach healthcare professionals, both at a primary and specialist level a multidisciplinary approach towards managing young women with breast cancer, both in the early and advanced setting.

Date and time: Mon 21 Jun 2021 from 9:30am to 4:30pm

Register here

Join us for a unique opportunity to look at the multifaceted approach towards young women with breast cancer, looking at the latest data from world-leading experts both at the treatment and support of women in these positions. This session will provide a multidisciplinary approach as well as an evaluation of the science and latest advances in the interpretation of this data.

In an interactive setting, we will be focusing on the latest updates on the scientific, clinical and psychosocial aspects of breast cancer in young women and the multidisciplinary management of the disease.

This webinar is for healthcare professionals only.

Learning objectives for the participants:

  • Management of advanced breast cancer with a particular emphasis on young women
  • Understanding the hereditary risk factors associated with breast cancer and have use of the NHS directory influences management
  • Fertility preservation procedures and pregnancy outcomes in women who have had previous breast cancer
  • Conference updates in breast cancer management with particular emphasis on the management of young women with breast cancer
  • Advising on lifestyle changes and mental health for women who have been diagnosed with breast cancer

A CPD certificate with 6 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.

Join in the conversation online #RSMLive 
Follow us on Twitter: @RoySocMed 

We would like to thank our sponsors AstraZeneca & Daiichi SankyoNovartisPierre-Fabre Ltd and Roche for their support of this webinar. Promotional symposium organised by Daiichi Sakyo and AstraZeneca is intended for Healthcare professionals.

Please note that the scientific programme and content has not been influenced in any way by the sponsors.


Welcome and Introduction

Dr Marina Parton and Dr Bhawna Sirohi

Session one

Dr Bhawna Sirohi

Patient speaker
The Leah Ledermann lecture – Managing advanced breast cancer in young women

Dr Fatima Cardoso, Director, Breast Unit, Champalimaud Clinical Centre, President ABC Global Alliance, Lisbon, Portugal

Panel discussion
Break and sponsor presentation

Kisqali and the treatment of pre-menopausal women – presentation by Novartis, given by Dr Mark Tuthill, Consultant Medical Oncologist, The Churchill Hospital, Oxford

Session two

Chair: Mr Henry Cain

Hereditary Breast cancer risk- what we now know

Dr Helen Hanson, Consultant in Cancer Geneticist, St George’s, University Hospital NHS Foundation Trust

The NHS genetics directory in the breast clinic

Dr Zoe Kemp, Consultant Geneticist, Royal Marsden Hospital

Panel discussion
Session three

Chair: Dr Susie Stanway

Fertility and pregnancy after breast cancer – real world data

Dr Yuliya Kopeika, Consultant Gynaecologist, Subspecialist in Reproductive medicine Guy’s and St Thomas’ Hospital NHS Foundation Trust

Panel discussion
Lunch break and Daiichi Sankyo and AstraZeneca sponsored symposium

Redefining expectations in third-line HER2+ metastatic breast cancer (mBC); given by Dr Alicia Okines, Consultant Medical Oncologist, from The Royal Marsden hospital.

Promotional symposium organised by Daiichi Sankyo and AstraZeneca is intended for HCPs only. Daiichi Sankyo and AstraZeneca have had no other involvement into the other aspects of this meeting

Session four

Chair: Dr Marina Parton

Conference reports ; whats new for young women with breast cancer

Dr Shaheenah Dawood, Head of Medical Oncology, Head of the Breast Cancer Program, Dubai, UAE

The potential of PARP inhibitors in breast cancer

Professor Andrew Tutt, Head of Division, Breast Cancer Research, The Institute of Cancer Research, Director of the Breast Cancer Now Research Centre, Institute of Cancer Research, and Breast Cancer Now Research Unit, Kings College London, Clinician Scientist, Consultant Clinical Oncologist in Breast Cancer

Panel discussion
Break and sponsor presentation

Addressing Health Disparities in Breast Cancer Clinical Research – presentation by Roche, given by Ed Merivale & Howard Turner

Session five

Chair: Dr Richard Simcock

Excercsing and breast cancer

Dr Caroline Wilson, Consultant Medical Oncologist Weston Park Cancer Centre, Sheffield, Honorary Clinical Senior Lecturer UoS and Dr Catherine Harper-Wynne, Consultant Medical Oncologist and Honorary Senior Lecturer University of Kent 

Diet and breast cancer

Dr Clare Shaw, Consultant Dietician, The Royal Marsden NHS Foundation Trust

Cognitive impairment during cancer treatment

Dr Stuart Anderson, Consultant Neuropsychologist, Independent Practice and Health and Social Care Directorate, States of Guernsey

The fear of cancer recurrence

Mr Ben Smith, CONCERT Co-Deputy Director (Policy and Practice) Conjoint Senior Lecturer, UNSW Sydney

Panel discussion
Closing remarks


The Royal Society of Medicine

More in this category

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x